PriceTargets.com logo

Colfax - CFX Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 04/4/2022 04:59 PM ET
+0 (0.00%)
Get New Colfax Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CFX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CFX

Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Colfax in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for CFX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Colfax. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/15/2022Morgan StanleyLower TargetEqual Weight$135.00 ➝ $123.00
3/15/2022KeyCorpLower TargetOverweight$180.00 ➝ $156.00
2/23/2022Stifel NicolausLower TargetBuy$174.00 ➝ $156.00
2/23/2022Robert W. BairdLower Target$198.00 ➝ $141.00
2/8/2022Seaport Res PtnDowngradeBuy ➝ Neutral
1/28/2022Morgan StanleyLower TargetEqual Weight$153.00 ➝ $135.00
1/14/2022Morgan StanleyLower TargetEqual Weight$168.00 ➝ $153.00
1/5/2022Loop CapitalInitiated CoverageHold$135.00
12/10/2021Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold$165.00 ➝ $162.00
11/5/2021Deutsche Bank AktiengesellschaftBoost TargetHold$144.00 ➝ $165.00
11/5/2021KeyCorpBoost TargetOverweight$171.00 ➝ $180.00
10/7/2021Morgan StanleyLower TargetEqual Weight$153.00 ➝ $150.00
10/4/2021BarclaysLower TargetUnderweight$132.00 ➝ $129.00
9/10/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral$159.00 ➝ $153.00
8/16/2021ArgusBoost TargetBuy$150.00 ➝ $168.00
8/2/2021Seaport Res PtnReiterated RatingBuy
7/30/2021Morgan StanleyBoost TargetEqual Weight$141.00 ➝ $153.00
4/30/2021Morgan StanleyBoost TargetEqual Weight$135.00 ➝ $141.00
4/13/2021BarclaysReiterated RatingEqual Weight ➝ Underweight$144.00 ➝ $135.00
4/12/2021Morgan StanleyBoost TargetEqual Weight$126.00 ➝ $135.00
4/6/2021BarclaysDowngradeEqual Weight ➝ Underweight$144.00 ➝ $135.00
3/12/2021Deutsche Bank AktiengesellschaftBoost TargetHold$159.00 ➝ $162.00
3/12/2021KeyCorpBoost TargetOverweight$141.00 ➝ $171.00
3/5/2021Deutsche Bank AktiengesellschaftBoost TargetHold$123.00 ➝ $129.00
2/25/2021Morgan StanleyBoost TargetEqual Weight$117.00 ➝ $126.00
2/22/2021CitigroupBoost Target$105.00 ➝ $123.00
2/19/2021BarclaysBoost TargetEqual Weight$105.00 ➝ $120.00
12/15/2020Morgan StanleyBoost TargetEqual Weight$90.00 ➝ $117.00
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.78 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 0 very positive mentions
  • 20 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
6/8/2025
  • 1 very positive mentions
  • 6 positive mentions
  • 4 negative mentions
  • 7 very negative mentions
Mentions as of
7/8/2025
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
Mentions as of
8/7/2025
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
9/6/2025
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
11/5/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Colfax logo
Colfax Corp. operates as a diversified technology company. The firm provides orthopedic care and fabrication technology products and services to customers. It operates through the following segments: Medical Technology and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $110.71
Low: $39.06
High: $127.50

52 Week Range

Now: N/A

Volume

101,542 shs

Average Volume

1,387,519 shs

Market Capitalization

$6.30 billion

P/E Ratio

84.91

Dividend Yield

N/A

Beta

2.12

Frequently Asked Questions

What sell-side analysts currently cover shares of Colfax?

The following Wall Street sell-side analysts have issued reports on Colfax in the last twelve months: Wall Street Zen.
View the latest analyst ratings for CFX.

What is the current price target for Colfax?

0 Wall Street analysts have set twelve-month price targets for Colfax in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Colfax in the next year.
View the latest price targets for CFX.

What is the current consensus analyst rating for Colfax?

Colfax currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CFX.

What other companies compete with Colfax?

Other companies that are similar to Colfax include Snap-On, Woodward, Pentair, ITT and RBC Bearings. Learn More about companies similar to Colfax.

How do I contact Colfax's investor relations team?

Colfax's physical mailing address is 420 NATIONAL BUSINESS PARKWAY 5TH FLOOR, ANNAPOLIS JUNCTION MD, 20701. The industrial products company's listed phone number is (302) 252-9160 and its investor relations email address is [email protected]. The official website for Colfax is www.colfaxcorp.com. Learn More about contacing Colfax investor relations.